Adamas Pharmaceuticals, Inc. ADMS

Adamas Pharmaceuticals, Inc. Total Liabilities 2011-2026 | ADMS

Annual Total Liabilities Adamas Pharmaceuticals, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
170 M	163 M	145 M	120 M	10.3 M	12.6 M	14.1 M	4.23 M	59.3 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
170 M	4.23 M	77.6 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	390 M	$ 3.54	-2.48 %	$ 1.06 B	Canada
I-Mab IMAB	707 M	-	-	$ 866 M	China
ADMA Biologics ADMA	147 M	$ 15.85	-4.2 %	$ 3.78 B	USA
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Aptorum Group Limited APM	4.35 M	$ 0.82	-0.79 %	$ 4.47 M	China
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Apellis Pharmaceuticals APLS	705 M	$ 20.39	2.67 %	$ 2.57 B	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
ANI Pharmaceuticals ANIP	855 M	$ 75.33	-1.57 %	$ 1.46 B	USA
Applied Therapeutics APLT	72 M	-	-	$ 8.42 M	USA
Autolus Therapeutics plc AUTL	355 M	$ 1.53	-6.44 %	$ 390 M	Britain
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Athersys ATHX	28.4 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
AVEO Pharmaceuticals AVEO	59.5 M	-	-	$ 521 M	USA
Corcept Therapeutics Incorporated CORT	189 M	$ 34.4	-3.61 %	$ 3.57 B	USA
Corbus Pharmaceuticals Holdings CRBP	35.2 M	$ 7.77	-7.72 %	$ 33.6 M	USA
Axsome Therapeutics AXSM	602 M	$ 162.29	-1.09 %	$ 8.07 B	USA
CorMedix CRMD	11.9 M	$ 6.52	-8.43 %	$ 332 M	USA
Champions Oncology CSBR	28.6 M	$ 5.85	-2.58 %	$ 79.9 M	USA
BridgeBio Pharma BBIO	3.01 B	$ 64.94	-2.41 %	$ 12.4 B	USA
Brainstorm Cell Therapeutics BCLI	9.6 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	137 M	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	3.83 B	-	0.49 %	$ 251 B	Cayman-islands
Denali Therapeutics DNLI	144 M	$ 19.72	-3.19 %	$ 3.24 B	USA
Bellicum Pharmaceuticals BLCM	3.77 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	84 M	-	-7.31 %	$ 87 M	USA
Edesa Biotech EDSA	1.83 M	$ 3.91	-8.43 %	$ 12.5 M	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
BioLineRx Ltd. BLRX	25.4 M	$ 2.86	1.78 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	1.51 B	$ 60.59	0.26 %	$ 11.6 B	USA
Equillium EQ	28 M	$ 1.7	-3.14 %	$ 59 M	USA
Burford Capital Limited BUR	1.45 B	$ 8.22	-1.85 %	$ 1.35 B	Britain